New anti-tuberculosis drugs: strategies, sources and new molecules.
about
Inaugural structure from the DUF3349 superfamily of proteins, Mycobacterium tuberculosis Rv0543cSolution-state NMR structure and biophysical characterization of zinc-substituted rubredoxin B (Rv3250c) from Mycobacterium tuberculosisBioPhytMol: a drug discovery community resource on anti-mycobacterial phytomolecules and plant extractsMycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesisAnimal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement.Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.Drug-resistant tuberculosis: emerging treatment options.Microbiological and Pharmacological Evaluation of the Micropropagated Rubus liebmannii Medicinal Plant.Identification of critical ligand binding determinants in Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase.A novel indigoid anti-tuberculosis agent.Terpenyl-purines from the sea.Challenges and opportunities in developing novel drugs for TB.Is repositioning of drugs a viable alternative in the treatment of tuberculosis?Mutation at G103 of MtbFtsZ Altered their Sensitivity to CoumarinsAntiprotozoal and Antimycobacterial Activities of Pure Compounds from Aristolochia elegans Rhizomes.Stereochemical analysis of leubethanol, an anti-TB-active serrulatane, from Leucophyllum frutescens.Developing countries can contribute to global health innovation.Classification and reporting of severity experienced by animals used in scientific procedures: FELASA/ECLAM/ESLAV Working Group report.Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment.
P2860
Q27666231-E304CD58-9ED7-4AC7-8697-56B69516A5DEQ27673638-9F305CBC-4D9A-4D37-B177-729274A7D9DCQ27902287-DA90C154-C136-4B98-AE73-5413820FF361Q28476148-B490BF13-C8AE-4785-8412-AE835AD8B461Q34460532-7D45DC3A-F931-44CA-887B-C77C3E677B6BQ35579500-DA91E788-13DB-44AE-8095-872BDB07FED7Q35683967-52FD92F8-8859-4F76-9A6B-7B9B1F32C82EQ36206639-6B949999-63A1-4EDE-A0CB-F7CFDB805321Q37358395-6339C0AD-F2D8-420C-9C8A-92BBB75BA67CQ37581199-807465FF-32C9-4E47-8625-96AB43D521D4Q37680690-75CC992E-92AA-41C2-834D-A472550E052AQ37924294-24A98E32-3D05-4E1A-A917-46D162F7AEE5Q38053000-E12B4836-AE75-489A-ADBB-391B3C731AA9Q42292706-77B9E2E7-8165-4B97-83CE-35D6E4DC2242Q42612800-A073A096-5CC1-4DD5-8EC7-595EA477C78CQ42727408-502562BB-23E0-435E-BB4E-76A9C25875A7Q44841672-0020ED76-81E8-456B-81EF-D7103D59C083Q47717563-A679DEBD-5232-4EC6-AAE8-1364DA87F9E7Q52568342-88067199-345B-4F73-A06E-98183D7149B7
P2860
New anti-tuberculosis drugs: strategies, sources and new molecules.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New anti-tuberculosis drugs: strategies, sources and new molecules.
@en
New anti-tuberculosis drugs: strategies, sources and new molecules.
@nl
type
label
New anti-tuberculosis drugs: strategies, sources and new molecules.
@en
New anti-tuberculosis drugs: strategies, sources and new molecules.
@nl
prefLabel
New anti-tuberculosis drugs: strategies, sources and new molecules.
@en
New anti-tuberculosis drugs: strategies, sources and new molecules.
@nl
P2093
P1476
New anti-tuberculosis drugs: strategies, sources and new molecules.
@en
P2093
Daniela Fernandes Ramos
Juan Carlos Palomino
Pedro Almeida da Silva
P304
P356
10.2174/092986709788186066
P577
2009-01-01T00:00:00Z